People with Fabry disease who develop antidrug antibodies (ADAs) against enzyme replacement therapy (ERT) tend to show higher levels of disease-related biomarkers and experience more infusion-related reactions than those without these antibodies. The review of 24 studies found the link between ADAs and kidney and heart outcomes was…
News
Direct genetic testing in Spanish adults at high risk for Fabry disease uncovered 10 previously unreported mutations in the GLA gene, a new study has found. “These findings highlight the value of direct genetic analysis in high-risk populations for identifying both known and previously unreported GLA variants,” noted researchers,…
Using a computer-assisted test on biopsy data from people with Fabry disease can automatically measure the amount of fatty buildup seen in the skin, helping to monitor the rare inherited condition, a new study shows. However, while this “automated image analysis” successfully spotted this buildup in both men and…
A middle-aged man with Fabry disease developed severe narrowing in all three major heart arteries despite receiving standard treatment and having well-controlled traditional cardiovascular risk factors, a case study from China reported. Tests revealed rapidly worsening coronary disease, with narrowing in the arteries that supply blood to the heart, along…
A large newborn screening (NBS) program in Japan identified 77 potential cases of Fabry disease from 2006 to 2022, according to a study. The number includes infants with genetic mutations known to cause Fabry disease, as well as infants with mutations that might be linked to the condition (variants…
Measurements of subtle eye changes in people with Fabry disease may offer a noninvasive way to support the early diagnosis and long-term monitoring of eye involvement in the rare genetic disorder, a study showed. Researchers found that pupils in people with Fabry recovered more slowly after exposure to light,…
Standard newborn screening tests for Fabry disease regularly miss female infants, leading to delays in their diagnosis and treatment compared with males, a new study reveals. Because current screening relies on measuring enzyme activity, the test is generally less reliable for girls, who…
A new guidebook aims to support young adults living with Fabry disease. The Fabry International Network (FIN) developed the guide in collaboration with a coalition of young adults with Fabry disease from around the world. “This guidebook was built with young adults, not simply for them,” Anna…
Oral treatment with Galafold (migalastat) helped keep kidney and heart function largely stable over years of follow-up in adults with Fabry disease, according to a real-world U.K. study. The therapy also significantly reduced blood levels of lyso-Gb3, a disease biomarker, in both people starting treatment for the first…
A single dose of an RNA-based gene therapy for Fabry disease produced long-lasting levels of the missing key enzyme and reduced the toxic buildup of fatty molecules linked to the disease, according to new preclinical data from Addition Therapeutics. The findings were presented in a poster at the…
Recent Posts
- New GLA gene mutation tied to heart-focused Fabry disease
- Heart changes may reveal late-onset Fabry disease, case report finds
- How one Fabry family stands together through joy and pain
- Study links drugs for type 2 diabetes to lower death risk in Fabry disease
- People with Fabry may be at higher risk of blood clots, study shows